| Salvia miltiorrhiza roots against cardiovascular disease: consideration of herb-drug interactions F Chen, L Li, DD Tian BioMed Research International 2017, 2017 | 44 | 2017 |
| Effects of Common CYP 1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis DD Tian, S Natesan, JR White, MF Paine Clinical and translational science 12 (1), 39-46, 2018 | 40 | 2018 |
| CYP3A4-mediated pharmacokinetic interactions in cancer therapy D Tian, Z Hu Current Drug Metabolism 15 (8), 808-817, 2014 | 34 | 2014 |
| Refined prediction of pharmacokinetic kratom-drug interactions: time-dependent inhibition considerations RS Tanna, DD Tian, NB Cech, NH Oberlies, AE Rettie, KE Thummel, ... Journal of Pharmacology and Experimental Therapeutics 376 (1), 64-73, 2021 | 25 | 2021 |
| Identification of intestinal UDP-glucuronosyltransferase inhibitors in green tea (Camellia sinensis) using a biochemometric approach: application to raloxifene as a test drug … DD Tian, JJ Kellogg, N Okut, NH Oberlies, NB Cech, DD Shen, ... Drug Metabolism and Disposition 46 (5), 552-560, 2018 | 25 | 2018 |
| Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail JT Nguyen, DD Tian, RS Tanna, DL Hadi, S Bansal, JC Calamia, ... Clinical Pharmacology & Therapeutics 109 (5), 1342-1352, 2021 | 24 | 2021 |
| Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen) D Tian, W Jia, X Liu, D Wang, J Liu, J Dong, L Li, F Du, F Xu, F Wang, ... Acta Pharmacologica Sinica 36 (5), 627-643, 2015 | 20 | 2015 |
| Strategies for improving the quantitative bioanalytical performance of LC-MS in pharmacokinetic studies L Li, D Tian, F Chen, J Yang, K Yu, Y Sun Current drug metabolism 13 (9), 1206-1212, 2012 | 20 | 2012 |
| Selection of priority natural products for evaluation as potential precipitants of natural product–drug interactions: a NaPDI center recommended approach EJ Johnson, V González-Peréz, DD Tian, YS Lin, JD Unadkat, AE Rettie, ... Drug Metabolism and Disposition 46 (7), 1046-1052, 2018 | 19 | 2018 |
| Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity JD Clarke, A Dzierlenga, T Arman, E Toth, H Li, KD Lynch, DD Tian, ... Toxicon 162, 1-8, 2019 | 17 | 2019 |
| Targeting obesity for the prevention of chronic cardiovascular disease through gut microbiota-herb interactions: An opportunity for traditional herbs F Chen, J Jiang, DD Tian, Q Wen, YH Li, JQ Zhang, C Cheng, T Wang Current Pharmaceutical Design 23 (8), 1142-1152, 2017 | 17 | 2017 |
| Peony-glycyrrhiza decoction, an herbal preparation, inhibits clozapine metabolism via cytochrome P450s, but not flavin-containing monooxygenase in in vitro models W Wang, DD Tian, B Zhang, D Wang, QR Tan, CY Wang, ZJ Zhang Drug Metabolism and Disposition 43 (7), 1147-1153, 2015 | 17 | 2015 |
| Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats DD Tian, W Wang, HN Wang, SCW Sze, ZJ Zhang Molecules 21 (6), 696, 2016 | 12 | 2016 |
| Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach EJ Cox, DD Tian, JD Clarke, AE Rettie, JD Unadkat, KE Thummel, ... Pharmacological Reviews 73 (2), 847-859, 2021 | 10 | 2021 |
| Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects MG McDonald, DD Tian, KE Thummel, MF Paine, AE Rettie Drug Metabolism and Disposition 48 (10), 1018-1027, 2020 | 10 | 2020 |
| A pharmacokinetic natural product-disease-drug interaction: a double hit of silymarin and nonalcoholic steatohepatitis on hepatic transporters in a rat model ML Montonye, DD Tian, T Arman, KD Lynch, B Hagenbuch, MF Paine, ... Journal of Pharmacology and Experimental Therapeutics 371 (2), 385-393, 2019 | 10 | 2019 |
| Indinavir increases midazolam N-glucuronidation in humans: identification of an alternate CYP3A inhibitor using an in vitro to in vivo approach DD Tian, C Leonowens, EJ Cox, V González-Pérez, KS Frederick, ... Drug Metabolism and Disposition 47 (7), 724-731, 2019 | 10 | 2019 |
| Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin‐drug interactions KD Lynch, ML Montonye, DD Tian, T Arman, VO Oyanna, BJ Bechtold, ... Phytotherapy Research 35 (6), 3286-3297, 2021 | 7 | 2021 |
| In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism W Wang, DD Tian, ZJ Zhang Molecules 21 (5), 597, 2016 | 4 | 2016 |
| Determining mechanisms underlying the goldenseal‐midazolam interaction in humans using an in vitro to in vivo extrapolation approach RS Tanna, DD Tian, MG McDonald, J Calamia, AE Rettie, KE Thummel, ... The FASEB Journal 33 (S1), 814.14-814.14, 2019 | 2 | 2019 |
